Four HHMI scientists are among those honored by the prestigious Royal Society.
Researchers obtain the first definitive look at how a protein often implicated in cancer development turns itself on to promote cell growth.
HHMI researchers have discovered how a new generation of drugs thwarts a deadly mutation that causes chronic myelogenous leukemia.
HHMI researchers identify 15 gene mutations that cause patients with chronic myeloid leukemia to develop resistance to Gleevec.
X-ray crystallography studies pinpoint how the drug STI-571 works against chronic myelogenous leukemia.